Recently, in a meta-analysis published by our group evaluating clinical trials that investigated antioxidant or anti-inflammatory actions in their treatments for IBD, only SOD was significantly modulated, while markers such as MDA, like our findings, and total antioxidant capacity showed no significant relevance [18]. Here, SOD1 is linked to inflammatory bowel disease.